DK393288A - Praeparat til saarheling og knogleregenerering - Google Patents

Praeparat til saarheling og knogleregenerering

Info

Publication number
DK393288A
DK393288A DK393288A DK393288A DK393288A DK 393288 A DK393288 A DK 393288A DK 393288 A DK393288 A DK 393288A DK 393288 A DK393288 A DK 393288A DK 393288 A DK393288 A DK 393288A
Authority
DK
Denmark
Prior art keywords
specimen
bone recovery
spray health
mammal
growth factor
Prior art date
Application number
DK393288A
Other languages
English (en)
Other versions
DK175889B1 (da
DK393288D0 (da
Inventor
Harry N Antoniades
Ray C Williams
Samuel E Lynch
Original Assignee
Inst Molecular Biology Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Molecular Biology Inc, Harvard College filed Critical Inst Molecular Biology Inc
Publication of DK393288D0 publication Critical patent/DK393288D0/da
Publication of DK393288A publication Critical patent/DK393288A/da
Application granted granted Critical
Publication of DK175889B1 publication Critical patent/DK175889B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198803932A 1986-11-14 1988-07-14 Sårheling og knogleregenerering DK175889B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93076286A 1986-11-14 1986-11-14
US93076286 1986-11-14
PCT/US1987/002975 WO1988003409A1 (en) 1986-11-14 1987-11-13 Wound healing and bone regeneration
US8702975 1987-11-13

Publications (3)

Publication Number Publication Date
DK393288D0 DK393288D0 (da) 1988-07-14
DK393288A true DK393288A (da) 1988-09-13
DK175889B1 DK175889B1 (da) 2005-05-30

Family

ID=25459724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803932A DK175889B1 (da) 1986-11-14 1988-07-14 Sårheling og knogleregenerering

Country Status (15)

Country Link
EP (1) EP0289584B1 (da)
JP (1) JPH01500199A (da)
KR (1) KR960005708B1 (da)
CN (1) CN1027346C (da)
AT (1) ATE88899T1 (da)
AU (1) AU600069B2 (da)
DE (1) DE3785758T2 (da)
DK (1) DK175889B1 (da)
IE (1) IE60517B1 (da)
MX (1) MX170454B (da)
NO (1) NO883127L (da)
NZ (1) NZ222551A (da)
OA (1) OA09159A (da)
WO (1) WO1988003409A1 (da)
ZA (1) ZA878566B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849407A (en) * 1986-08-13 1989-07-18 Zymogenetics, Inc. Biologically active mosaic proteins
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
ZA9010332B (en) * 1989-12-22 1991-08-28 Ciba Geigy Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
ATE156363T1 (de) * 1990-04-10 1997-08-15 Inst Molecular Biology Inc Wundheilung
WO1991018622A1 (en) * 1990-05-30 1991-12-12 President And Fellows Of Harvard College Wound healing
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
WO1993008825A1 (en) * 1991-11-04 1993-05-13 Zymogenetics, Inc. Pdgf gel formulation
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
EP0602210A1 (en) * 1992-06-08 1994-06-22 Pharmacia AB (reg.number 556131-9608) Use of growth factor igf-i and/or igf-ii
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
CN1055023C (zh) * 1993-01-03 2000-08-02 周至譓 伤口护理剂
EP0804562B1 (en) 1994-07-12 2002-10-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
ATE274056T1 (de) * 1995-10-11 2004-09-15 Chiron Corp Kombination pdgf, kgf, igf und igfbp zur wundheilung
JP4275741B2 (ja) 1996-12-13 2009-06-10 ノバルティス バクシンズ アンド ダイアグノスティックス， インコーポレーテッド 血小板由来増殖因子タンパク質の分析および分離
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7241874B2 (en) 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2007061889A2 (en) 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
WO2007092622A2 (en) 2006-02-09 2007-08-16 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
EP2049145B1 (en) 2006-06-30 2018-03-14 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP3181157B1 (en) 2006-11-03 2019-08-14 BioMimetic Therapeutics, LLC Compositions and methods for arthrodetic procedures
RU2010137106A (ru) 2008-02-07 2012-03-20 Байомайметик Терапьютикс, Инк. (Us) Композиции и способы для дистракциионного остеогенеза
CN102231992B (zh) 2008-09-09 2015-05-20 生物模拟治疗公司 用于治疗肌腱和韧带损伤的血小板衍生生长因子的组合物和方法
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
CN102397534B (zh) * 2010-09-07 2013-10-23 中国人民解放军总医院 胰岛素在制备促进颌骨组织愈合的药物中的用途
KR101965592B1 (ko) * 2011-11-22 2019-08-13 (주)아모레퍼시픽 성장 인자를 포함하는 피부 재생 촉진제
WO2016061219A1 (en) 2014-10-14 2016-04-21 Samuel Lynch Compositions for treating wounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor

Also Published As

Publication number Publication date
NO883127D0 (no) 1988-07-13
DE3785758D1 (de) 1993-06-09
NZ222551A (en) 1989-11-28
DE3785758T2 (de) 1993-08-05
EP0289584A4 (en) 1990-01-08
ZA878566B (en) 1989-07-26
MX170454B (es) 1993-08-24
JPH01500199A (ja) 1989-01-26
CN87101250A (zh) 1988-06-08
KR960005708B1 (ko) 1996-05-01
IE873075L (en) 1988-05-14
EP0289584B1 (en) 1993-05-05
WO1988003409A1 (en) 1988-05-19
NO883127L (no) 1988-09-12
KR890700033A (ko) 1989-03-02
ATE88899T1 (de) 1993-05-15
DK175889B1 (da) 2005-05-30
JPH0581569B2 (da) 1993-11-15
AU600069B2 (en) 1990-08-02
IE60517B1 (en) 1994-07-27
CN1027346C (zh) 1995-01-11
EP0289584A1 (en) 1988-11-09
OA09159A (en) 1992-03-31
DK393288D0 (da) 1988-07-14
AU8328987A (en) 1988-06-01

Similar Documents

Publication Publication Date Title
DK393288D0 (da) Praeparat til saarheling og knogleregenerering
ATE109352T1 (de) Heilung von wunden.
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
IT8448318A0 (it) Procedimento e composizione per la decontaminazione del suolo da composti organici polialogenati
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK83388D0 (da) Farmaceutisk middel indeholdende den insulin-lignende vaekstfaktor ii (igf-ii) til topisk anvendelse til saarheling
KR890007782A (ko) 산성 기체 흡수제 조성물
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DK0479799T3 (da) Sårheling
PT87523A (pt) Mischkristalle aus insulin und insulinderivaten verfahren zur herstellung dieser mischkristalle diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
DE3775510D1 (de) Bindungsinduzierende komposition.
DK204686D0 (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
PT83309A (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
IT1164176B (it) Composizione per un'applicazione topica contenente,come sostanza attiva sull'elasticia',la morbidezza della pelle tiamorfolinone oppure uno dei suoi derivati
DE3373978D1 (en) Composition for the care or treatment of the human skin
DK44184D0 (da) Kosmetik
IT8168548A0 (it) Composizione per la profilassi e la cura della dissenteria suina o per l incremento della crescita dei suini
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
IT8711803A0 (it) Soluzione per la cura della alopecia

Legal Events

Date Code Title Description
PUP Patent expired